NCT04728854View on ClinicalTrials.gov

Telederm and Bullous Pemphigoid

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

March 15, 2021

Primary Completion Date

October 6, 2023

Study Completion Date

October 6, 2023

Conditions
Bullous Pemphigoid
Trial Locations (1)

30322

Emory Dermatology Clinic, Atlanta

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Emory University

OTHER

NCT04728854 - Telederm and Bullous Pemphigoid | Biotech Hunter | Biotech Hunter